Northwestern University researchers have developed the first selective therapy to prevent allergic reactions, ranging in severity from itchy hives and watery eyes to trouble breathing and even death.A scanning electron microscope image of nanoparticles (colorized in purple) that have successfully entered a mast cell To develop the new therapy, researchers decorated nanoparticles with antibodies capable...
by Johns Hopkins University In a study led by Johns Hopkins Medicine, in collaboration with Yale School of Medicine, researchers have identified a biomarker found via a simple urine test that can be used to diagnose acute tubulointerstitial nephritis (AIN), a medical condition that causes inflammation of the kidneys and can lead to acute kidney injury (AKI)—a sudden...
So, you had a severe allergic reaction to your first COVID-19 shot. Does that doom you to the same after your second shot? Apparently not, claims a new analysis that found the risk of a second vaccine dose reaction is extremely low. Right now, the recommendation for someone who has had a severe reaction to...
by American College of Allergy, Asthma, and Immunology Some people in the United States have expressed concern over getting one of the three currently available COVID-19 vaccines due to fear of an allergic reaction to the ingredients. Two new studies being presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific...
